Notch1/2/3/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer.

Abstract

Notch refers to a set of genes encoding a family of transmembrane receptors in mammalian cells. Previous evidence indicated that Notch receptors were implicated in the onset of gastric cancer. However, there is little evidence on the different genetic expression patterns of the four Notch receptors and their values for patient prognosis. Most recently, we investigated the transcriptional data of Notch receptors and related patient survival in patients with GC based on several databases, including ONCOMINE, GEPIA, Kaplan-Meier Plotter, cBioPortal and TIMER. According to our findings, gastric cancer tissues, compared with adjacent normal tissues presented a higher level of expression of Notch1/2/3. We also performed a survival analysis and noted that gastric cancer patients with high transcription levels of Notch1/2/3/4 had a low relapse-free survival. In gastric cancer patients, higher levels of infiltration in their CD4+ T cells, macrophages, neutrophils, and dendritic cells were positive associated with the expression of Notch receptors. Notch expression had significant association with diverse immune marker sets in gastric cancer. Overall, this study provides evidence that Notch1/2/3/4 could become the potential targets for precision treatment and new biomarkers in the prognosis of gastric cancer.

• Authors: Jian Hu, Jianghong Yu, Jun Gan, Ning Song, Liubin Shi, Jie Liu, Ziqiang Zhang, Jianjun Du
• Journal: Aging (Aging (Albany NY)) Vol. 12 Issue 3 Pg. 2595-2609 (02 06 2020) ISSN: 1945-4589 [Electronic] United States
• PMID: 32028262 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers, Tumor
• Receptors, Notch

Topics

• Biomarkers, Tumor (immunology, metabolism)
• Female
• Humans
• Male
• Prognosis
• Receptors, Notch (immunology, metabolism)
• Stomach Neoplasms (immunology, mortality, pathology)